Testosterone undecylenate

Testosterone undecylenate
Clinical data
Trade names	Durasteron, Triolandren (mixtures)
Other names	TUe; Testosterone undecenoate; 17β-Hydroxyandrost-4-en-3-one 17β-(undec-10-enoate)
Routes of; administration	Intramuscular injection
Drug class	Androgen; Anabolic steroid; Androgen ester
Identifiers
	IUPAC name [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undec-10-enoate;
CAS Number	29430-26-0;
PubChem CID	9846790;
ChemSpider	21229627;
ECHA InfoCard	100.045.099
Chemical and physical data
Formula	C30H46O3
Molar mass	454.695 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C)CCC4=CC(=O)CC[C@]34C;
	InChI InChI=1S/C30H46O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h4,21,24-27H,1,5-20H2,2-3H3/t24-,25-,26-,27-,29-,30-/m0/s1; Key:PBFYIQCFOZXSKC-CNQKSJKFSA-N;

Testosterone undecylenate (TUe) is an androgen/anabolic steroid medication and androgen ester which is no longer marketed.[1][2][3] It was a component of Durasteron and Triolandren, long-acting mixtures of testosterone esters in oil solution that were administered by intramuscular injection.[4][5][6][7]

References

Shapiro, Seymour L.; Weinburg, Kurt.; Freedman, Louis. (1956). "Notes - Long-Acting Androgens". The Journal of Organic Chemistry. 21 (11): 1300–1302. doi:10.1021/jo01117a602. ISSN 0022-3263.
Gould, David; Finckenor, Lawrence; Hershberg, E. B.; Cassidy, James; Perlman, Preston L. (1957). "Long-acting Testosterone Esters. Some Considerations on their Biological Utilization1". Journal of the American Chemical Society. 79 (16): 4472–4475. doi:10.1021/ja01573a061. ISSN 0002-7863.
https://patents.google.com/patent/US2855341
Hans Schuermann; Rudolf Doepfmer (1960). Fertilitätsstörungen beim Manne. Springer-Verlag. pp. 260–. ISBN 978-3-642-94784-1.
Joachim Ufer (1960). Hormontherapie in der Frauenheilkunde: Grundlagen und Praxis. Gruyter. p. 153.
Aakvaag, Asbjørn; Vogt, Jørgen H. (1969). "Plasma testosterone values in different forms of testosterone treatment". Acta Endocrinologica. 60 (3): 537–542. doi:10.1530/acta.0.0600537. ISSN 0804-4643. PMID 5395873. Triolandren®, for intramuscular use, kindly supplied by Ciba, Basel, through Kobro 8c Co., Oslo, containing three different testosterone esters, in the following amounts of testosterone equivalents per ml oil: propionate 20 mg; valerate 80 mg; undecylenate 150 mg.
Zachmann, Milo; Prader, Andrea (1970). "Anabolic and Androgenic Effect of Testosterone in Sexually Immature Boys and Its Dependency on Growth Hormone". The Journal of Clinical Endocrinology & Metabolism. 30 (1): 85–95. doi:10.1210/jcem-30-1-85. ISSN 0021-972X. Triolandren, CIBA; 250 mg of this preparation contains 20 mg of testosterone propionate, 80 mg of testosterone-n-valerianate, and 150 mg of testosterone undecylenate—250 mg thus contains 173.8 mg of testosterone; the remaining 76.2 mg consists of the ester components [...]

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[ShapiroWeinburg1956-1] Shapiro, Seymour L.; Weinburg, Kurt.; Freedman, Louis. (1956). "Notes - Long-Acting Androgens". The Journal of Organic Chemistry. 21 (11): 1300–1302. doi:10.1021/jo01117a602. ISSN 0022-3263.

[GouldFinckenor1957-2] Gould, David; Finckenor, Lawrence; Hershberg, E. B.; Cassidy, James; Perlman, Preston L. (1957). "Long-acting Testosterone Esters. Some Considerations on their Biological Utilization1". Journal of the American Chemical Society. 79 (16): 4472–4475. doi:10.1021/ja01573a061. ISSN 0002-7863.

[US2855341A-3] ttps://patents.google.com/patent/US2855341

[SchuermannDoepfmer1960-4] Hans Schuermann; Rudolf Doepfmer (1960). Fertilitätsstörungen beim Manne. Springer-Verlag. pp. 260–. ISBN 978-3-642-94784-1.

[Ufer1960-5] Joachim Ufer (1960). Hormontherapie in der Frauenheilkunde: Grundlagen und Praxis. Gruyter. p. 153.

[pmid5395873-6] Aakvaag, Asbjørn; Vogt, Jørgen H. (1969). "Plasma testosterone values in different forms of testosterone treatment". Acta Endocrinologica. 60 (3): 537–542. doi:10.1530/acta.0.0600537. ISSN 0804-4643. PMID 5395873. Triolandren®, for intramuscular use, kindly supplied by Ciba, Basel, through Kobro 8c Co., Oslo, containing three different testosterone esters, in the following amounts of testosterone equivalents per ml oil: propionate 20 mg; valerate 80 mg; undecylenate 150 mg.

[ZachmannPrader1970-7] Zachmann, Milo; Prader, Andrea (1970). "Anabolic and Androgenic Effect of Testosterone in Sexually Immature Boys and Its Dependency on Growth Hormone". The Journal of Clinical Endocrinology & Metabolism. 30 (1): 85–95. doi:10.1210/jcem-30-1-85. ISSN 0021-972X. Triolandren, CIBA; 250 mg of this preparation contains 20 mg of testosterone propionate, 80 mg of testosterone-n-valerianate, and 150 mg of testosterone undecylenate—250 mg thus contains 173.8 mg of testosterone; the remaining 76.2 mg consists of the ester components [...]

Testosterone undecylenate

See also

References